Inactive Instrument

Analyst Reco. Trillium Therapeutics

Equities

Benchmark Downgrades Trillium Therapeutics to Hold From Buy	21-11-17	MT
TRILLIUM THERAPEUTICS : Benchmark Adjusts Price Target for Trillium Therapeutics to C$23.34 From C$26.41, Maintains Buy Rating	21-08-24	MT
Today on Wall Street: A new central bank theory	21-08-24
TRILLIUM THERAPEUTICS : Craig-Hallum Downgrades Trillium Therapeutics to Hold From Buy	21-08-24	MT
TRILLIUM THERAPEUTICS : JMP Securities Downgrades Trillium Therapeutics to Market Perform From Market Outperform	21-08-24	MT
ANALYST RECOMMENDATIONS : M&S, Estee Lauder, Planet Fitness, Snowflake, Steel Dynamics...	21-08-24
TRILLIUM THERAPEUTICS : HC Wainwright Downgrades Trillium Therapeutics to Neutral From Buy, Adjusts Price Target to $18.50 From $22	21-08-23	MT
TRILLIUM THERAPEUTICS : Benchmark Starts Trillium Therapeutics at Buy With $21 Price Target	21-04-14	MT
TRILLIUM THERAPEUTICS : HC Wainwright Adjusts Trillium Therapeutics' Price Target to $22 From $16.50, Keeps at Buy	20-11-18	MT

No results for this search